Genomic Vision announced the launch of FiberSmart®?, an innovative, Artificial Intelligence (AI)-based technology aimed at automating the detection and quantification of fluorescent signals on combed DNA molecules. Initially, FiberSmart®? will be available for the analysis of Replication Combing Assays (RCA), Genomic Vision's proprietary method for the direct visualization of DNA replication kinetics at the single molecule level.

The software leverages advanced AI methods to visualize, detect and analyze DNA replication kinetics up to three times more accurately and up to ten times faster than Genomic Vision's existing software solutions. Ergonomically designed, FiberSmart®? offers a simple and user-friendly interface, allowing fast analysis of DNA replication signals to deduce essential parameters describing replication kinetics.

The technology was successfully tested and validated by AstraZeneca, and the Fritz Lipmann Institute, Germany. The software is compatible with Genomic Vision's suite of scanners FiberVision®? and FiberVision-S®?

for the RCA assay of the Company's proprietary DNA combing technology, which has multiple potential applications including in cell and gene therapy quality control.